Search Results

There are 2313 results for: content related to: Long-term anticoagulant effects of CYP2C9 and VKORC1 genotypes in phenprocoumon users

  1. Vitamin K1 in oral solution or tablets: a crossover trial and two randomized controlled trials to compare effects

    Journal of Thrombosis and Haemostasis

    Volume 12, Issue 12, December 2014, Pages: 2017–2023, N. van Rein, E. P. A. Gebuis, W. M. Lijfering, J. J. E. Groeneveld, F. A. L. van der Horst, S. le Cessie, F. R. Rosendaal and F. J. M. van der Meer

    Article first published online : 7 NOV 2014, DOI: 10.1111/jth.12753

  2. Metformin use decreases the anticoagulant effect of phenprocoumon

    Journal of Thrombosis and Haemostasis

    Volume 12, Issue 6, June 2014, Pages: 887–890, J. C. F. Wijnen, I. R. van de Riet, W. M. Lijfering and F. J. M. van der Meer

    Article first published online : 10 JUN 2014, DOI: 10.1111/jth.12578

  3. Antithrombotic triple therapy and coagulation activation at the site of thrombus formation: a randomized trial in healthy subjects

    Journal of Thrombosis and Haemostasis

    Volume 12, Issue 11, November 2014, Pages: 1850–1860, S. Weisshaar, B. Litschauer, G. Gouya, P. Mayer, L. Smerda, S. Kapiotis, P. A. Kyrle, S. Eichinger and M. Wolzt

    Article first published online : 16 OCT 2014, DOI: 10.1111/jth.12726

  4. You have free access to this content
    An evaluation of gene–gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 5, May 2012, Pages: 767–772, R. M. F. VAN SCHIE, A. M. V. BABAJEFF, T. SCHALEKAMP, J. A. M. WESSELS, S. LE CESSIE, A. de BOER, F. J. M. VAN DER MEER, E. VAN MEEGEN, T. I. VERHOEF, F. R. ROSENDAAL, A. H. MAITLAND-VAN DER ZEE and FOR THE EU-PACT STUDY GROUP

    Article first published online : 2 MAY 2012, DOI: 10.1111/j.1538-7836.2012.04694.x

  5. You have free access to this content
    Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon

    British Journal of Clinical Pharmacology

    Volume 77, Issue 4, April 2014, Pages: 626–641, Talitha I. Verhoef, William K. Redekop, Ann K. Daly, Rianne M. F. van Schie, Anthonius de Boer and Anke-Hilse Maitland-van der Zee

    Article first published online : 20 MAR 2014, DOI: 10.1111/bcp.12220

  6. You have free access to this content
    The effect of omeprazole and esomeprazole on the maintenance dose of phenprocoumon

    British Journal of Clinical Pharmacology

    Volume 74, Issue 6, December 2012, Pages: 1068–1069, Talitha I. Verhoef, Miranda J. L. Zuurhout, Rianne M. F. van Schie, William K. Redekop, Felix J. M. van der Meer, Saskia le Cessie, Tom Schalekamp, Anthonius de Boer and Anke Hilse Maitland-van der Zee

    Article first published online : 13 NOV 2012, DOI: 10.1111/j.1365-2125.2012.04295.x

  7. Fluorescent investigations of binding of phenprocoumon to α1-acid glycoprotein

    Journal of Pharmaceutical Sciences

    Volume 76, Issue 8, August 1987, Pages: 646–649, M. Otagiri, T. Maruyama, T. Imai and Y. Imamura

    Article first published online : 16 SEP 2006, DOI: 10.1002/jps.2600760812

  8. You have free access to this content
    Evaluation of the effects of single-nucleotide polymorphisms in CYP3A4 and CYP4F2 on stable phenprocoumon and acenocoumarol maintenance doses

    Journal of Thrombosis and Haemostasis

    Volume 11, Issue 6, June 2013, Pages: 1200–1203, R. M. F. van Schie, A. Aoussar, F. J. M. van der Meer, A. de Boer and A. H. Maitland-van der Zee

    Article first published online : 3 JUL 2013, DOI: 10.1111/jth.12195

  9. You have free access to this content
    Course of the International Normalized Ratio in response to oral vitamin K1 in patients overanticoagulated with phenprocoumon

    British Journal of Haematology

    Volume 104, Issue 2, February 1999, Pages: 241–245, F. J. A. Penning-van Beest, F. R. Rosendaal, D. E. Grobbee, E. Van Meegen and B. H. Ch. Stricker

    Article first published online : 25 DEC 2001, DOI: 10.1046/j.1365-2141.1999.01196.x

  10. Risk of intracerebral hemorrhage associated with phenprocoumon exposure: a nested case–control study in a large population-based German database

    Pharmacoepidemiology and Drug Safety

    Volume 19, Issue 7, July 2010, Pages: 722–730, Sigrid Behr, Frank Andersohn and Edeltraut Garbe

    Article first published online : 13 MAY 2010, DOI: 10.1002/pds.1973

  11. Influence of Fatty Acids on the Binding of Warfarin and Phenprocoumon to Human Serum Albumin with Relation to Anticoagulant Therapy

    Journal of Pharmacy and Pharmacology

    Volume 48, Issue 8, August 1996, Pages: 870–875, Henrik Vorum and Bent Honoré

    Article first published online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1996.tb03990.x

  12. Age-dependent differences in the effect of phenprocoumon on the vitamin K1-epoxide cycle in rats

    Journal of Pharmacy and Pharmacology

    Volume 32, Issue 1, September 1980, Pages: 828–832, DIETMAR TRENK, DIETER BEERMANN, FRANZ OESCH and EBERHARD JÄHNCHEN

    Article first published online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1980.tb13085.x

  13. You have free access to this content
    Pharmacokinetic and pharmacodynamic interactions between phenprocoumon and atenolol or metoprolol.

    British Journal of Clinical Pharmacology

    Volume 17, Issue S1, February 1984, Pages: 97S–102S, H Spahn, W Kirch, E Mutschler, EE Ohnhaus, NR Kitteringham, HJ Logering and D Paar

    Article first published online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1984.tb02439.x

  14. You have free access to this content
    Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon.

    British Journal of Clinical Pharmacology

    Volume 30, Issue 1, July 1990, Pages: 115–118, H Monig, C Baese, HT Heidemann, EE Ohnhaus and HM Schulte

    Article first published online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1990.tb03750.x

  15. Metabolic fate of phenprocoumon in humans

    Journal of Pharmaceutical Sciences

    Volume 74, Issue 10, October 1985, Pages: 1037–1040, Stephen Toon, Larry D. Heimark, William F. Trager and Robert A. O'Reilly

    Article first published online : 17 SEP 2006, DOI: 10.1002/jps.2600741003

  16. DOUBLE BLIND TRIAL OF LONG-TERM ANTICOAGULANT TREATMENT AFTER MYOCARDIAL INFARCTION

    Acta Medica Scandinavica

    Volume 186, Issue 1-6, January/December 1969, Pages: 361–368, O. J. A. T. Meuwissen, A. C. Vervoorn, O. Cohen, F. L. J. Jordan and F. A. Nelemans

    Article first published online : 24 APR 2009, DOI: 10.1111/j.0954-6820.1969.tb01488.x

  17. Effects of CYP2C9 Polymorphisms on Phenprocoumon Anticoagulation Status

    Clinical Pharmacology & Therapeutics

    Volume 77, Issue 4, April 2005, Pages: 335–336, Mike Ufer

    Article first published online : 2 APR 2005, DOI: 10.1016/j.clpt.2005.01.012

  18. The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans

    Clinical Pharmacology & Therapeutics

    Volume 42, Issue 3, September 1987, Pages: 312–319, Larry D Heimark, Stephen Toon, Milo Gibaldi, William F Trager, Robert A O'Reilly and Darklis A Goulart

    Article first published online : 21 SEP 1987, DOI: 10.1038/clpt.1987.154

  19. Does additional confounder information alter the estimated risk of bleeding associated with phenprocoumon use—results of a two-phase study

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 535–545, Sigrid Behr, Walter Schill and Iris Pigeot

    Article first published online : 2 FEB 2012, DOI: 10.1002/pds.3193

  20. A New Algorithm for Weekly Phenprocoumon Dose Variation in a Southern Brazilian Population: Role for CYP2C9, CYP3A4/5 and VKORC1 Genes Polymorphisms

    Basic & Clinical Pharmacology & Toxicology

    Volume 114, Issue 4, April 2014, Pages: 323–329, Mariana R. Botton, Patrícia P. Viola, Eliane Bandinelli, Tiago L. L. Leiria, Luis E. P. Rohde and Mara H. Hutz

    Article first published online : 7 DEC 2013, DOI: 10.1111/bcpt.12172